3 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
potentially life-threatening organ injury. Despite treatment advances, MM is not curable and while current treatments are able to slow progression
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
REGN
29 Apr 24
pressure in the eye, eye discomfort, pain, or irritation, blurred vision, vitreous (gel-like substance) floaters, vitreous detachment, injury
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
7 Apr 24
-threatening organ injury. Despite treatment advances, MM is not curable and while current treatments are able to slow progression of the cancer, most
- Prev
- 1
- Next